PMC:7344504 / 5219-6416
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T13 | 375-381 | Body_part | denotes | throat | http://purl.org/sig/ont/fma/fma228738 |
| T14 | 546-551 | Body_part | denotes | blood | http://purl.org/sig/ont/fma/fma9670 |
| T15 | 724-729 | Body_part | denotes | chest | http://purl.org/sig/ont/fma/fma9576 |
| T16 | 999-1012 | Body_part | denotes | noradrenaline | http://purl.org/sig/ont/fma/fma61799 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T9 | 375-381 | Body_part | denotes | throat | http://purl.obolibrary.org/obo/UBERON_0000341 |
| T10 | 546-551 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/UBERON_0000178 |
| T11 | 724-729 | Body_part | denotes | chest | http://purl.obolibrary.org/obo/UBERON_0001443 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 149 | 836-845 | Gene | denotes | factor Xa | Gene:2159 |
| 150 | 270-277 | Species | denotes | patient | Tax:9606 |
| 151 | 937-944 | Species | denotes | patient | Tax:9606 |
| 152 | 34-40 | Chemical | denotes | oxygen | MESH:D010100 |
| 153 | 127-138 | Chemical | denotes | ceftriaxone | MESH:D002443 |
| 154 | 217-231 | Chemical | denotes | amphotericin B | MESH:D000666 |
| 155 | 246-256 | Chemical | denotes | tobramycin | MESH:D014031 |
| 156 | 279-290 | Chemical | denotes | ceftriaxone | MESH:D002443 |
| 157 | 819-830 | Chemical | denotes | enoxaparine | MESH:D017984 |
| 158 | 999-1012 | Chemical | denotes | noradrenaline | MESH:D009638 |
| 159 | 1047-1061 | Chemical | denotes | hydrocortisone | MESH:D006854 |
| 160 | 785-801 | Disease | denotes | pulmonary emboli | MESH:D011655 |
| 161 | 1150-1173 | Disease | denotes | tricuspid insufficiency | MESH:D014262 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T32 | 1150-1173 | Disease | denotes | tricuspid insufficiency | http://purl.obolibrary.org/obo/MONDO_0002870 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T35 | 172-173 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T36 | 230-231 | http://purl.obolibrary.org/obo/CLO_0001021 | denotes | B |
| T37 | 502-503 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T38 | 546-551 | http://purl.obolibrary.org/obo/UBERON_0000178 | denotes | blood |
| T39 | 546-551 | http://www.ebi.ac.uk/efo/EFO_0000296 | denotes | blood |
| T40 | 675-676 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T41 | 700-701 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
| T42 | 724-729 | http://www.ebi.ac.uk/efo/EFO_0000965 | denotes | chest |
| T43 | 1142-1143 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T33 | 34-40 | Chemical | denotes | oxygen | http://purl.obolibrary.org/obo/CHEBI_25805 |
| T34 | 127-138 | Chemical | denotes | ceftriaxone | http://purl.obolibrary.org/obo/CHEBI_29007 |
| T35 | 217-231 | Chemical | denotes | amphotericin B | http://purl.obolibrary.org/obo/CHEBI_2682 |
| T36 | 233-241 | Chemical | denotes | colistin | http://purl.obolibrary.org/obo/CHEBI_37943 |
| T37 | 246-256 | Chemical | denotes | tobramycin | http://purl.obolibrary.org/obo/CHEBI_28864|http://purl.obolibrary.org/obo/CHEBI_73678 |
| T39 | 279-290 | Chemical | denotes | ceftriaxone | http://purl.obolibrary.org/obo/CHEBI_29007 |
| T40 | 999-1012 | Chemical | denotes | noradrenaline | http://purl.obolibrary.org/obo/CHEBI_33569 |
| T41 | 1047-1061 | Chemical | denotes | hydrocortisone | http://purl.obolibrary.org/obo/CHEBI_17650 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T47 | 0-143 | Sentence | denotes | In the ICU, HFNO (high-flow nasal oxygen therapy) and selective digestive decontamination (SDD) were initiated, which includes ceftriaxone i.v. |
| T48 | 144-261 | Sentence | denotes | 2000 mg q24h for 4 days and a combined oral non-absorbable suspension of amphotericin B, colistin and tobramycin q6h. |
| T49 | 262-333 | Sentence | denotes | In this patient, ceftriaxone was continued de facto for another 4 days. |
| T50 | 334-494 | Sentence | denotes | Routine bacterial and fungal (peri-anal, throat and tracheal aspirate) surveillance cultures were done twice weekly in adherence with our local SDD policy [13]. |
| T51 | 495-625 | Sentence | denotes | Within a few hours after admission to the ICU, her blood oxygenation became insufficient with HFNO at FiO2 100% and 60 L/min flow. |
| T52 | 626-699 | Sentence | denotes | Therefore, she was sedated, intubated and put on a mechanical ventilator. |
| T53 | 700-802 | Sentence | denotes | A CT angiography of the chest was performed which demonstrated significant bilateral pulmonary emboli. |
| T54 | 803-885 | Sentence | denotes | Anticoagulants (enoxaparine anti-factor Xa) were initiated in therapeutic dosages. |
| T55 | 886-963 | Sentence | denotes | Pressure control ventilation was required with the patient in prone position. |
| T56 | 964-1115 | Sentence | denotes | Because of the need for increasing noradrenaline dosages during circulatory shock, hydrocortisone 100 mg q8h was initiated and continued for five days. |
| T57 | 1116-1197 | Sentence | denotes | Cardiac ultrasound showed a minor tricuspid insufficiency but no major pathology. |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T15 | 1040-1045 | Phenotype | denotes | shock | http://purl.obolibrary.org/obo/HP_0031273 |
| T16 | 1150-1173 | Phenotype | denotes | tricuspid insufficiency | http://purl.obolibrary.org/obo/HP_0005180 |